Abstract
IntroductionProsthetic valve endocarditis is a diagnostic and therapeutic challenge; 18F-FDG PET/CT has seen increasing use and has been incorporated in the latest ESC endocarditis guidelines. Follow-up by PET/CT has never been studied. The aim was to study the use of PET/CT to help predicting recurrences after full antibiotic treatment. MethodsFrom January 2011 to April 2016, all patients presenting with definite or possible prosthetic valve endocarditis were included and had a PET/CT after admission. After discharge, non-operated patients had a second PET/CT from 6 to 10 weeks after the end of intravenous antibiotic treatment, in addition to clinical and echocardiographic follow-up. ResultsAmong 276 patients with prosthetic valve admitted for suspicion of infective endocarditis, 43 of them with an abnormal prosthetic uptake on the first PET/CT had a second PET/CT within a mean period of 67.3 days after the end of intravenous antibiotic treatment. The mean follow-up was 414 days. Five recurrences occurred among the 34 patients with persistent abnormal prosthetic uptake on second PET/CT, there was no recurrence among the nine patients who had no more abnormal prosthetic uptake. ConclusionThis is the first study to evaluate the potential benefits of PET/CT for medically treated PVE follow-up. All recurrences occurred among patients with persistent abnormal prosthetic uptake on second PET/CT. An unexpected finding was the potential of bone-marrow and splenic uptake evolution, which is underused in IE and showed an interesting potential in the prognosis of these patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
